Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin

We report on a patient with tardive dyskinesia (TDK) treated with aripiprazole, a third-generation antipsychotic with partial D2 agonist-antagonist activity at both the dopamine and serotonin receptors. The patient’s condition improved with administration of a combination of tetrabenazine, botulinum...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar, Lourdes, Lorenzo, Carolina, Fernández-Ovejero, Raquel, Roncero, Carlos, Montejo, Angel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435569/
https://www.ncbi.nlm.nih.gov/pubmed/30949057
http://dx.doi.org/10.3389/fphar.2019.00281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435569/
https://www.ncbi.nlm.nih.gov/pubmed/30949057
http://dx.doi.org/10.3389/fphar.2019.00281

Ejemplares similares